Joe Proietto

Dr. Joe Proietto is a prominent Australian endocrinologist and a professor emeritus at the University of Melbourne, known for his research in obesity treatment and management. As a former board member of the World Obesity Federation, he has been instrumental in advocating for the use of GLP-1 receptor agonists, such as Ozempic, in treating obesity and related health conditions. Proietto's work has highlighted the complexities of obesity treatment, emphasizing both the potential of new medications and the challenges posed by weight regain.